Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2008-03-13
- Completion:
- 2007-10-31
Conditions
- Non-Small Cell Lung Cancer
Interventions
- DRUG
No Results Yet